Questions swirl about oversight in diluted chemo drugs

With nearly 1,200 Canadian cancer patients being told this month that they received watered-down chemotherapy drugs, there are now questions about who was in charge of overseeing the private company that prepared those drugs.

Afficher le reportage au complet